Skip to main content
. Author manuscript; available in PMC: 2012 Aug 9.
Published in final edited form as: Cancer Gene Ther. 2011 Jan 14;18(4):265–274. doi: 10.1038/cgt.2010.77

Fig. 6.

Fig. 6

Therapy with tumor-targeted interleukin 12 does not delay wound healing. Incision healing seven days after surgery in the untreated control group (A) and the ttIL-12 group (B). There was no significant difference in the time to complete epithelialization between the control and ttIL-12 EGT groups (p=0.54)